Recent Posts
- S2419: Phase III Double Blinded Trial of Immune-based Therapy with a Live Biotherapeutic MO-03 or Placebo for Frontline Therapy of Advanced Clear Cell Renal Cell Carcinoma [BIOFRONT Trial] NCT#07383441
- A082402: Involved-Station, Intensity-Modulated Post-Operative Radiation Therapy (I²-Port) for Resected Non-Small Cell Lung Cancer with Residual Mediastinal Adenopathy after Neoadjuvant Therapy (ypn2))
- EA1242: A Phase III Trial of Rx Therapy Guided by Genomic Risk Assessment For High Anatomic Stage ER-pos/HER2-neg Breast Cancer with RS<25 (RxFINE-Low)
- A072301: Phase III trial of radiotherapy followed by adjuvant temozolomide in combination with the IDH inhibitor vorasidenib vs. placebo in IDH-mutated newly-diagnosed grade 3 astrocytomas (NCT07215910)
- BGB-43395-302 (KANDELA-302)
Recent Comments
No comments to show.


